The Trump administration has once again thrown its weight behind "improved" untested and more deadly jabs, this time by granting Fast Track designation to ARCT-2304, a self-amplifying mRNA vaccine for H5N1 avian influenza.
The self-amplifying mRNA (SAM) vaccine works by encoding both the antigen of interest and the viral replication machinery. Once the mRNA is delivered into the host cell, it is translated to produce the antigen protein as well as the replication enzymes. These enzymes then amplify the mRNA within the cell, leading to increased expression of the antigen protein and a stronger immune response (I.e., the body trying to detox itself) compared to traditional mRNA vaccines that do not amplify themselves.
This amplification process mimics a viral infection, resulting in sustained levels of the target protein and self-adjuvanting innate immune responses, which ultimately lead to long-lasting antigen-specific humoral and cellular immune (detoxification) responses.
In other words, these new v2.0 jabs are more deadly, and even harder to detox. Formerly with v1.0 jabs the mRNA from the jab would teach many cells in your body's cells how to produce toxins, before the body managed to flush the mRNA from the body. But, now, with the v2.0 jabs, the cells are now also taught how to produce more self-replicating mRNA, so the process of replication can go on, despite the body's efforts to detox itself. This way, jabbed bodies can become factories of mRNA, themselves.